MedTrace Logo

Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy

NCT00782847 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2008-10-31

No results posted yet for this study

Summary

This study is designated to evaluate the effect of a patients' educational program called DiaNe® for consultation and support people with diabetic kidney disease in an early stage. The aim of the study is to examine if the program is suitable to stop deterioration of kidney function and to maintain or improve glycemic control. The consultation and support program DiaNe® substantially contributes to a better understanding of the affected clients for this complex clinical picture, allows them for specific interventions and creates the rationale for an active therapeutic relationship.

Conditions

  • Diabetic Nephropathy

Interventions

BEHAVIORAL

DiaNe consultation and support program

the DiaNe consultation and support program for clients with diabetic nephropathy consists of 4 sessions at 90-120 minutes conducted every week in a period of 4 weeks

Sponsors & Collaborators

  • Roche Pharma Deutschland GmbH, Grenzach-Wyhlen, Germany

    collaborator UNKNOWN

  • Institute for Medical Outcom Research GmbH, Loerrach, Germany

    collaborator UNKNOWN

  • DiaNe HCM GmbH

    lead OTHER

Principal Investigators

  • Ludwig F Merker, MD · Diabetes- und Nierenzentrum Dormagen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2007-01-31
Completion
2007-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782847 on ClinicalTrials.gov